Antioxidant property of pramnipexole independent of dopamine receptor activation in neuroprotection

Weidong Le, J. Jankovic, W. Xie, Stanley H. Appel

Research output: Contribution to journalArticlepeer-review

94 Scopus citations


Pramipexole and several other dopamine agonists have been recently demonstrated to have neuroprotective effects in vitro and in vivo. We report here that pramipexole can protect DAergic cell line MES 23.5 against dopamine (DA), 6-hydroxydopamine (6-OHDA), and hydrogen peroxide (H2O2)-induced cytotoxicity in vitro possibly through antioxidant effects, and such neuroprotection could not be blocked by selective D2 or D3 antagonists. Incubation with pramipexole (5-20μM) in MES 23.5 cell cultures increased cellular levels of glutathione (GSH), and elevated glutathione peroxidase (GSH-Px) and catalase activities, but only marginally enhanced SOD activity. Pretreatment with D2 or D3 antagonists did not block the stimulating effects of pramipexole on the cellular levels of GSH, and on the activities of GSH-Px and catalase in MES 23.5 cells. These results indicate that pramipexole's neuroprotective effects are likely associated with its antioxidant property independent of D2/D3 receptor activation.

Original languageEnglish (US)
Pages (from-to)1165-1173
Number of pages9
JournalJournal of Neural Transmission
Issue number10
StatePublished - Nov 20 2000


  • D2/D3 receptors
  • Dopamine agonist
  • Neuroprotection
  • Oxidative stress
  • Pramipexole

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Antioxidant property of pramnipexole independent of dopamine receptor activation in neuroprotection'. Together they form a unique fingerprint.

Cite this